Navigation Links
Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs
Date:5/2/2011

M.D., CEO of CTI. "This was the right decision in the interests of patients with relapsed refractory aggressive NHL beyond second line therapy for whom there are no approved or effective drugs." 

As a result of this important new development, the Company plans to move quickly to request a meeting with the appropriate Division of the FDA's Office of Oncology Drug Products and to submit the requested information, as well as all other relevant data requested in the Complete Response Letter, in a re-submission as soon as practical.  Under the Prescription Drug User Fee Act ("PDUFA") guidelines, the re-submitted NDA would have a 6 month review cycle.

Conference Call Information

On Tuesday, May 3, 2011, at 8:30 a.m. Eastern time/2:30 p.m. Central European time/5:30 a.m. Pacific time, members of CTI's management team will host a conference call.

Conference Call Numbers
Tuesday, May 3, 2011 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time

1-877-941-9205 (US Participants – Toll-Free)
1-480-629-9835 (US Participants)

800-149-070 (Italy Participants – Toll-Free)
39-02-30-350-9038 (Italy Participants)

Call-back numbers for post-listening available at 11:30 a.m. Eastern Time:

1-800-406-7325 (US Participants)
1-303-590-3030 (International)

Passcode: 4438455#

Live audio webcast at www.celltherapeutics.com will be archived for post-call listening approximately two hours after call ends.

About Pixantrone

Pixantrone is a novel aza-anthracenedione that has distinct structural and physio-chemical properties that make its anti-tumor activity unique in this class of agents. Similar to anthracyclines, pixantrone inhibits Topo-isomerase II but unlike anthracyclines--rather than intercalation with DNA---- pixantrone alkylates DNA-- forming stable DNA adducts wi
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff
2. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
3. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
4. United Therapeutics Corporation Reports First Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants
6. Prime Therapeutics President and CEO Eric Elliott Delivers Speech at University of Minnesota College of Pharmacy Dialogues in Managed Care Leadership 2011
7. Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results
8. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
9. New Biopharmaceutical Company to Accelerate Delivery of Vaccines and Protein Therapeutics
10. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
11. Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015  The report on breast ... of breast cancer drugs on the basis of the ... originates from the inner lining of milk ducts or ... malignant type of tumor that can spread to other ... which starts in lobules is referred as lobular carcinoma, ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... coil is used to treat an unruptured and ... artery wall). The treatment is either known as ... procedure, the endovascular coil blocks the blood flow ... usually performed under general anaesthesia by an interventional ...
(Date:9/2/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Wells ... is welcome to participate in the conference through ... Fargo Securities Healthcare ConferencePresenter: Ron Squarer, Chief Executive ... a.m. Eastern Time Webcast: www.arraybiopharma.com   ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Neuroendovascular Coil Market 2015-2019 2
... LOS ANGELES, Oct. 24, 2011 NeuroSigma, Inc., a ... has signed a contract with the University of California, ... clinical trial to study the use of non-invasive, external ... Deficit Hyperactivity Disorder (ADHD).  NeuroSigma is the exclusive worldwide ...
... HealthWarehouse.com, Inc. (OTC: HEWA), a leading VIPPS-accredited ... begin providing prescription medications for WhiteGlove Health, Inc., ... excited to have a national partner to provide ... Robert Fabbio, co-founder and chief executive officer of ...
Cached Medicine Technology:NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD 2NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD 3WhiteGlove Health Selects HealthWarehouse.com to Provide Prescription Medications to its Members Nationwide 2
(Date:9/2/2015)... ... September 02, 2015 , ... Alameda County Community Food ... Action Month” during the entire month of September. In the spirit of ... its efforts this September to an awareness campaign educating legislators and the public ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Cancer Center at Children's Healthcare of Atlanta to help support childhood cancer ... discuss the upcoming WSB Radio Care-A-Thon , which is the fund-raising event ...
(Date:9/2/2015)... ... September 02, 2015 , ... Medical ... has completed a recapitalization with new investment partners Beecken Petty O’Keefe & ... each offer extensive expertise and connections within the healthcare industry, which makes ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Every year ... it; others dread it. However, few are prepared to face the academic workload confronting ... starts. Our schools haven’t prepared them since schools don’t teach students how to study. ...
(Date:9/2/2015)... Destin, Florida (PRWEB) , ... September 02, 2015 , ... ... in drug prices over the past year and its negative impact on consumers. It ... regular prescription medication and 10% were paying as much as an extra $100 compared ...
Breaking Medicine News(10 mins):Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
... says hazard isn,t proven, , SATURDAY, Sept. 5 (HealthDay ... (pronounced THAL ates) are nearly ubiquitous in consumer products, ... plastics and toys. , A little over a decade ... began to focus on phthalates and have been working ...
... , ST. LOUIS, Sept, 4 KV ... Thomas McHugh, the Vice President of Finance and Corporate Controller of ... Mr. McHugh replaces Ronald J. Kanterman, who ceased serving as ... Mr. Kanterman continues to serve as a member of the ...
... NEWPORT BEACH, Calif., Sept. 4 Nationwide Health Properties ... Portfolio Officer, Abdo Khoury, will participate on a healthcare real estate ... Conference on Friday, September 11, 2009 beginning at 7:30 a.m. CDT. ... a live audio-webcast, please us the following link: ...
... University of Toronto have identified a protein which plays ... could enhance our understanding of how the brain works, ... of T graduate student John Calarco, working in the ... and Biomolecular Research, University of Toronto) and Prof. Mei ...
... major episode later, researchers say , FRIDAY, Sept. 4 ... to have major depression, anxiety disorders and eating disorders ... researchers interviewed 755 teenagers who were about age 16 ... substance abuse. , About 8 percent were found to ...
... ... ... American Pharmacists Association (APhA) is recommending that the public begin visiting their ... 80,000 pharmacists have been trained to administer immunizations and have the authority to administer ...
Cached Medicine News:Health News:In Toys and More, Are Chemicals Safe or Harmful? 2Health News:In Toys and More, Are Chemicals Safe or Harmful? 3Health News:KV Pharmaceutical Appoints Interim Chief Financial Officer 2Health News:KV Pharmaceutical Appoints Interim Chief Financial Officer 3Health News:KV Pharmaceutical Appoints Interim Chief Financial Officer 4Health News:KV Pharmaceutical Appoints Interim Chief Financial Officer 5Health News:KV Pharmaceutical Appoints Interim Chief Financial Officer 6Health News:U of T researchers identify protein 2Health News:Depressed Teens Continue to Suffer 2Health News:Pharmacists Urge the Public to Begin Getting Immunized 2Health News:Pharmacists Urge the Public to Begin Getting Immunized 3
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... Decapping System DS 800 selectively removes closures from ... the barcode towards the rack opening in one ... integrated in PVT Systems like Sorting System RS ... Sorter RSD ProVolume and Aliquoting System RSD 800A. ...
... Nanogen offers reagents to detect ... human parainfluenza virus 1, 2 and ... and respiratory syncytial virus A and ... reagents to create homebrew tests., ...
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
Medicine Products: